About Dropprint Genomics
Dropprint Genomics is a company based in San Francisco (United States) founded in 2019 by Rachel E. Gate, Jimmie Ye, and Meena Subramaniam was acquired by Immunai in March 2021. Dropprint Genomics has raised $150 thousand across 1 funding round from investors including Immunai Technologies and Y Combinator. Dropprint Genomics operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
- Headquarter San Francisco, United States
- Founders Rachel E. Gate, Jimmie Ye, Meena Subramaniam
- SectorsHealthcare
- Email••••••••
- Website dropprintgen.com
- Acquired by Immunai (Mar 2021)
- Total Equity Funding$150K (USD)
in 1 rounds
- Latest Funding Round$150K (USD), Seed
Mar 2020
- InvestorsImmunai Technologies
& 1 more
- Acquired byImmunai
(Mar 2021)
Funding Insights of Dropprint Genomics
Dropprint Genomics has successfully raised a total of $150K through 1 strategic funding round. The most recent funding activity was a Seed round of $150 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150,000
- Total Rounds 1
- Last Round Seed — $150,000
- First Round $150,000
(Mar 2020)
- Investors Count 1
All 1 funding rounds of Dropprint Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $150,000 | Seed | – | Y Combinator | – |
2 investors in total: 2 institutional.
Investors in Dropprint Genomics
Dropprint Genomics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Immunai Technologies and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | – | ycombinator.com | Mountain View, United States | |
Next-generation immunomodulatory therapeutics are developed using multi-omic analysis. | 2018 | immunai.com | United States |
Investor details for Dropprint Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dropprint Genomics
3 people are tracked at Dropprint Genomics (3 in leadership).
| Name | Role | Group |
|---|---|---|
Rachel E. Gate | Co-Founder & CEO | Leadership |
Jimmie Ye | Co-Founder & Advisor | Leadership |
Meena Subramaniam | Co-Founder & CTO | Leadership |
Complete people profiles for Dropprint Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dropprint Genomics
3 dated milestones of Dropprint Genomics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Dropprint Genomics is founded.
- Funding First funding round of $150K.
- Exit Acquired by Immunai.
Competitors of Dropprint Genomics
Dropprint Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| mgrc.com.my | 2004 | Kuala Lumpur, Malaysia | – | – | Genome sequencing, analysis, and genetic screening services are provided. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. |
Detailed competitors of Dropprint Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dropprint Genomics
Complete news archive for Dropprint Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Dropprint Genomics
10 companies that operate in the same segment as Dropprint Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dropprint Genomics
Dropprint Genomics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Dropprint Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Rachel E. Gate is the current CEO of Dropprint Genomics. They have also founded this company.
Dropprint Genomics is a funded company, having raised a total of $150K across 1 funding round to date. The company's 1st funding round was a Seed of $150K, raised on Mar 2020.
Dropprint Genomics was founded in 2019 in San Francisco, United States, within the genomics sector. Single-cell technology is employed by the company to generate gene datasets targeted at drug development for immune-based diseases. Machine learning models are applied to analyze and characterize data from extensive populations, facilitating insights into immune system functions. Operations focus on profiling large-scale genetic information for therapeutic applications.
Dropprint Genomics's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Dropprint Genomics has 2 investors. Key investors include Immunai Technologies, and Y Combinator.
Yes. Dropprint Genomics was acquired by Immunai in March 2021.